Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
1.520
-0.070 (-4.40%)
At close: Apr 21, 2026, 4:00 PM EDT
1.510
-0.010 (-0.66%)
After-hours: Apr 21, 2026, 4:00 PM EDT
Innate Pharma Employees
Innate Pharma had 174 employees as of June 30, 2025.
Employees
174
Change
n/a
Growth
n/a
Revenue / Employee
$60,764
Profits / Employee
-$331,838
Market Cap
138.74M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 174 | - | - |
| Dec 31, 2024 | 181 | 2 | 1.12% |
| Dec 31, 2023 | 179 | -32 | -15.17% |
| Dec 31, 2022 | 211 | -4 | -1.86% |
| Dec 31, 2021 | 215 | -29 | -11.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Humacyte | 184 |
| Fate Therapeutics | 161 |
| Molecular Partners AG | 134 |
| Connect Biopharma Holdings | 64 |
| Biomea Fusion | 41 |
| Spero Therapeutics | 25 |
| Tiziana Life Sciences | 9 |
| Galectin Therapeutics | 9 |
IPHA News
- 4 days ago - Innate Pharma SA: Innate Pharma to Present MATISSE Phase 2 Interim Results of IPH5201 in Clinical Trials Plenary Session at AACR 2026 - Finanz Nachrichten
- 4 days ago - Innate Pharma to Present MATISSE Phase 2 Interim Results of IPH5201 in Clinical Trials Plenary Session at AACR 2026 - Business Wire
- 8 days ago - Innate Pharma SA: Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 21, 2026 - Finanz Nachrichten
- 8 days ago - Innate Pharma SA: Number of Shares and Voting Rights of Innate Pharma as of April 9, 2026 - Finanz Nachrichten
- 8 days ago - Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 21, 2026 - Business Wire
- 8 days ago - Number of Shares and Voting Rights of Innate Pharma as of April 9, 2026 - Business Wire
- 13 days ago - Innate Pharma SA: Innate Pharma to Present at the AACR 2026 Oncology Industry Partnering Event - Finanz Nachrichten
- 13 days ago - Innate Pharma to Present at the AACR 2026 Oncology Industry Partnering Event - Business Wire